{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T02:44:23Z","timestamp":1746413063628,"version":"3.37.3"},"reference-count":47,"publisher":"BMJ","issue":"12","funder":[{"name":"National Key Research and Development Program of China","award":["2017YFA0104500, 2016YFC0904100, 2016YFC0904103"],"award-info":[{"award-number":["2017YFA0104500, 2016YFC0904100, 2016YFC0904103"]}]},{"name":"The Open Project of Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform","award":["JSRB2021-03, TC2022B005"],"award-info":[{"award-number":["JSRB2021-03, TC2022B005"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>X-linked Alport syndrome (XLAS) caused by<jats:italic>COL4A5<\/jats:italic>pathogenic variants usually has heterogeneous phenotypes in female patients. The genetic characteristics and glomerular basement membrane (GBM) morphological changes in women with XLAS need to been further investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 83 women and 187 men with causative<jats:italic>COL4A5<\/jats:italic>variants were enrolled for comparative analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Women were more frequently carrying de novo<jats:italic>COL4A5<\/jats:italic>variants compared with men (47% vs 8%, p=0.001). The clinical manifestations in women were variable, and no genotype\u2013phenotype correlation was observed. Coinherited podocyte-related genes, including<jats:italic>TRPC6<\/jats:italic>,<jats:italic>TBC1D8B<\/jats:italic>,<jats:italic>INF2<\/jats:italic>and<jats:italic>MYH9<\/jats:italic>, were identified in two women and five men, and the modifying effects of coinherited genes contributed to the heterogeneous phenotypes in these patients. X-chromosome inactivation (XCI) analysis of 16 women showed that 25% were skewed XCI. One patient preferentially expressing the mutant<jats:italic>COL4A5<\/jats:italic>gene developed moderate proteinuria, and two patients preferentially expressing the wild-type<jats:italic>COL4A5<\/jats:italic>gene presented with haematuria only. GBM ultrastructural evaluation demonstrated that the degree of GBM lesions was associated with the decline in kidney function for both genders, but more severe GBM changes were found in men compared with women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The high frequency of de novo variants carried by women indicates that the lack of family history tends to make them susceptible to be underdiagnosed. Coinherited podocyte-related genes are potential contributors to the heterogeneous phenotype of some women. Furthermore, the association between the degree of GBM lesions and decline in kidney function is valuable in evaluating the prognosis for patients with XLAS.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jmg-2023-109221","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T17:26:10Z","timestamp":1684949170000},"page":"1169-1176","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic features and kidney morphological changes in women with X-linked Alport syndrome"],"prefix":"10.1136","volume":"60","author":[{"given":"Hongling","family":"Di","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erzhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-0726","authenticated-orcid":false,"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"2023112709101243000_60.12.1169.1","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.2174\/0929867328666210108113500","article-title":"Alport syndrome: a comprehensive review on Genetics, pathophysiology, histology, clinical and therapeutic perspectives","volume":"28","author":"Pedrosa","year":"2021","journal-title":"Curr Med Chem"},{"key":"2023112709101243000_60.12.1169.2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009070784"},{"key":"2023112709101243000_60.12.1169.3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00467-020-04748-4","article-title":"Long-term outcome among females with Alport syndrome from a single pediatric center","volume":"36","author":"Goka","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"2023112709101243000_60.12.1169.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000090034.71205.74"},{"key":"2023112709101243000_60.12.1169.5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","article-title":"Natural history and genotype-phenotype correlation in female X-linked Alport syndrome","volume":"2","author":"Yamamura","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2023112709101243000_60.12.1169.6","doi-asserted-by":"crossref","unstructured":"Mastrangelo A , Giani M , Groppali E , et al . X-linked Alport syndrome in women: genotype and clinical course in 24 cases. Front Med (Lausanne) 2020;7:580376. doi:10.3389\/fmed.2020.580376","DOI":"10.3389\/fmed.2020.580376"},{"key":"2023112709101243000_60.12.1169.7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.19171220"},{"key":"2023112709101243000_60.12.1169.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.038"},{"key":"2023112709101243000_60.12.1169.9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.7.1218"},{"key":"2023112709101243000_60.12.1169.10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018030228"},{"key":"2023112709101243000_60.12.1169.11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V114649"},{"key":"2023112709101243000_60.12.1169.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-011-1836-7"},{"key":"2023112709101243000_60.12.1169.13","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00580116"},{"key":"2023112709101243000_60.12.1169.14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ekir.2016.09.056","article-title":"Negative staining for COL4A5 correlates with worse prognosis and more severe ultrastructural alterations in males with Alport syndrome","volume":"2","author":"Said","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2023112709101243000_60.12.1169.15","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1093\/ndt\/gfac002","article-title":"Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome","volume":"37","author":"Di","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2023112709101243000_60.12.1169.16","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.055244"},{"key":"2023112709101243000_60.12.1169.17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3629"},{"key":"2023112709101243000_60.12.1169.18","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3597"},{"key":"2023112709101243000_60.12.1169.19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000492438","article-title":"Diagnosing Alport syndrome: lessons from the pediatric ward","volume":"140","author":"Vos","year":"2018","journal-title":"Nephron"},{"key":"2023112709101243000_60.12.1169.20","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-#"},{"key":"2023112709101243000_60.12.1169.21","doi-asserted-by":"crossref","unstructured":"Hadjipanagi D , Papagregoriou G , Koutsofti C , et al . Novel and founder pathogenic variants in X-linked Alport syndrome families in Greece. Genes (Basel) 2022;13:2203. doi:10.3390\/genes13122203","DOI":"10.3390\/genes13122203"},{"key":"2023112709101243000_60.12.1169.22","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ekir.2022.08.021","article-title":"A systematic review of pathogenic COL4A5 variants and proteinuria in women and girls with X-linked Alport syndrome","volume":"7","author":"Gibson","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2023112709101243000_60.12.1169.23","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102822"},{"key":"2023112709101243000_60.12.1169.24","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13150"},{"key":"2023112709101243000_60.12.1169.25","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.252"},{"key":"2023112709101243000_60.12.1169.26","doi-asserted-by":"crossref","unstructured":"Voskarides K , Papagregoriou G , Hadjipanagi D , et al . COL4A5 and LAMA5 variants Co-inherited in familial hematuria: digenic inheritance or genetic modifier effect? BMC Nephrol 2018;19:114. doi:10.1186\/s12882-018-0906-5","DOI":"10.1186\/s12882-018-0906-5"},{"key":"2023112709101243000_60.12.1169.27","doi-asserted-by":"crossref","unstructured":"Daga S , Fallerini C , Furini S , et al . Non-collagen genes role in Digenic Alport syndrome. BMC Nephrol 2019;20:70. doi:10.1186\/s12882-019-1258-5","DOI":"10.1186\/s12882-019-1258-5"},{"key":"2023112709101243000_60.12.1169.28","doi-asserted-by":"crossref","unstructured":"Frese J , Kettwig M , Zappel H , et al . Kidney injury by variants in the COL4A5 Gene aggravated by polymorphisms in slit diaphragm genes causes focal segmental Glomerulosclerosis. Int J Mol Sci 2019;20:519. doi:10.3390\/ijms20030519","DOI":"10.3390\/ijms20030519"},{"key":"2023112709101243000_60.12.1169.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0934-7"},{"key":"2023112709101243000_60.12.1169.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3067-9"},{"key":"2023112709101243000_60.12.1169.31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000432406","article-title":"Co-inheritance of functional Podocin variants with heterozygous collagen IV mutations predisposes to renal failure","volume":"130","author":"Stefanou","year":"2015","journal-title":"Nephron"},{"key":"2023112709101243000_60.12.1169.32","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017090997"},{"key":"2023112709101243000_60.12.1169.33","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11440919"},{"key":"2023112709101243000_60.12.1169.34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019040414"},{"key":"2023112709101243000_60.12.1169.35","doi-asserted-by":"publisher","DOI":"10.1038\/ng.505"},{"key":"2023112709101243000_60.12.1169.36","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50028"},{"key":"2023112709101243000_60.12.1169.37","doi-asserted-by":"publisher","DOI":"10.1038\/ng1592"},{"key":"2023112709101243000_60.12.1169.38","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008101086"},{"key":"2023112709101243000_60.12.1169.39"},{"key":"2023112709101243000_60.12.1169.40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117862"},{"key":"2023112709101243000_60.12.1169.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1514-1"},{"key":"2023112709101243000_60.12.1169.42","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp551"},{"key":"2023112709101243000_60.12.1169.43","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.29.9.663"},{"key":"2023112709101243000_60.12.1169.44","doi-asserted-by":"publisher","DOI":"10.1007\/s004390000382"},{"key":"2023112709101243000_60.12.1169.45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.chembiol.2018.02.003","article-title":"A split-Luciferase-based Trimer formation assay as a high-throughput screening platform for Therapeutics in Alport syndrome","volume":"25","author":"Omachi","year":"2018","journal-title":"Cell Chem Biol"},{"key":"2023112709101243000_60.12.1169.46","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.479"},{"key":"2023112709101243000_60.12.1169.47","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13378"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2023-109221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T17:12:22Z","timestamp":1701105142000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2023-109221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,11,27]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/jmg-2023-109221"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2023-109221","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"type":"print","value":"0022-2593"},{"type":"electronic","value":"1468-6244"}],"subject":[],"published":{"date-parts":[[2023,5,24]]}}}